CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)	12 Months Ended
	Aug. 31, 2024	Aug. 31, 2023
Income Statement [Abstract]
Revenue	$ 0	$ 0
Operating expenses
Selling, general and administrative	2,011,899	1,546,177
Research and development	593,988	764,827
Total operating expenses	2,605,887	2,311,004
Loss from operations	(2,605,887)	(2,311,004)
Other income (expense)
Interest income	242,371	246,491
Impairment of fixed assets	(683,950)	0
Total other income (expense)	(441,579)	246,491
Net loss from continuing operations	(3,047,466)	(2,064,513)
Net loss from discontinued operations	(7,949)	(331,882)
Deemed dividend attributable to warrant modification	(400,000)	0
Net loss attributable to common stockholders	(3,455,415)	(2,396,395)
Other comprehensive income (loss)
Foreign currency translation gain/(loss)	1,457	(4,528)
Comprehensive income (loss)	$ (3,453,958)	$ (2,400,923)
Loss per Share from continuing operations basic	$ (0.06)	$ (0.04)
Loss per Share from continuing operations diluted	(0.06)	(0.04)
Loss per Share from discontinued operations basic	(0.00)	(0.01)
Loss per Share from discontinued operations diluted	(0.00)	(0.01)
Loss per Share basic	(0.06)	(0.04)
Loss per Share diluted	$ (0.06)	$ (0.04)
Weighted average number of common shares outstanding - basic	53,198,399	53,198,399
Weighted average number of common shares outstanding - diluted	53,198,399	53,198,399